Sorry, you need to enable JavaScript to visit this website.

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Category & Conditions: Neurological Diseases and Conditions
Study Phase : 2/3
Medicine: Nurtec® ODT (Rimegepant)
Language: English
ViewDownloadPrint
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 2/3
Medicine: Nurtec® ODT (Rimegepant)
Language: English
ViewDownloadPrint
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 1
Medicine: PF-07258669
Language: English
ViewDownloadPrint
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-07260437
Language: English
ViewDownloadPrint
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-08046046 (SGN-ALP)
Language: Swedish
ViewDownloadPrint
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-08046046 (SGN-ALP)
Language: English
ViewDownloadPrint
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-08046046 (SGN-ALP)
Language: Spanish
ViewDownloadPrint
Category & Conditions: Respiratory Disease
Study Phase : 3
Medicine: Combination COVID-19 and Influenza modRNA Vaccine (PF-07926307)
Language: English
ViewDownloadPrint
Category & Conditions: Respiratory Disease
Study Phase : 1/2
Medicine: Combination COVID-19 and Influenza modRNA Vaccine (PF-07926307)
Language: English
ViewDownloadPrint
Category & Conditions: Respiratory Disease
Study Phase : 1/2
Medicine: Combination COVID-19 and Influenza modRNA Vaccine (PF-07926307)
Report Type: Final
Language: English
ViewDownloadPrint